Cited by 224Genetic Neurodegenerative DiseasesPluripotent Stem Cells ResearchGenetics and Neurodevelopmental Disorders

Developmental alterations in Huntington’s disease neural cells and pharmacological rescue in cells and mice

Open access
The HD iPSC Consortium, Lim, Ryan G, Salazar, Lisa L, Wilton, Daniel K, King, Alvin R, Stocksdale, Jennifer T, Sharifabad, Delaram, Lau, Alice L +44 more·2017·Nature Neuroscience

Abstract

Neural cultures derived from Huntington's disease (HD) patient-derived induced pluripotent stem cells were used for 'omics' analyses to identify mechanisms underlying neurodegeneration. RNA-seq analysis identified genes in glutamate and GABA signaling, axonal guidance and calcium influx whose expression was decreased in HD cultures. One-third of gene changes were in pathways regulating neuronal development and maturation. When mapped to stages of mouse striatal development, the profiles aligned with earlier embryonic stages of neuronal differentiation. We observed a strong correlation between HD-related histone marks, gene expression and unique peak profiles associated with dysregulated genes, suggesting a coordinated epigenetic program. Treatment with isoxazole-9, which targets key dysregulated pathways, led to amelioration of expanded polyglutamine repeat-associated phenotypes in neural cells and of cognitive impairment and synaptic pathology in HD model R6/2 mice. These data suggest that mutant huntingtin impairs neurodevelopmental pathways that could disrupt synaptic homeostasis and increase vulnerability to the pathologic consequence of expanded polyglutamine repeats over time.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.4532

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
The HD iPSC Consortium, Lim, R. G., Salazar, L. L., Wilton, D. K., King, A. R., Stocksdale, J. T., Sharifabad, D., Lau, A. L., Stevens, B., Reidling, J. C., Winokur, S. T., Casale, M. S., Thompson, L. M., Pardo, M., Díaz-Barriga, A. G. G., Straccia, M., Sanders, P., Alberch, J., Canals, J. M., Kaye, J. A., Dunlap, M., Jo, L., May, H., Mount, E., Anderson-Bergman, C., Haston, K., Finkbeiner, S., Kedaigle, A. J., Gipson, T. A., Yildirim, F., Ng, C. W., Milani, P., Housman, D. E., Fraenkel, E., Allen, N. D., Kemp, P. J., Atwal, R. S., Biagioli, M., Gusella, J. F., MacDonald, M. E., Akimov, S. S., Arbez, N., Stewart, J., Ross, C. A., Mattis, V. B., Tom, C. M., Ornelas, L., Sahabian, A., Lenaeus, L., Mandefro, B., Sareen, D., & Svendsen, C. N.
Affiliations
  • University of California, Irvine (US)
  • Boston Children's Hospital (US)
  • Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
  • Gladstone Institutes (US)
  • Sandia National Laboratories California (US)
  • Massachusetts Institute of Technology (US)
  • Cardiff University (GB)
  • Massachusetts General Hospital (US)
  • Johns Hopkins University (US)
  • Cedars-Sinai Medical Center (US)
Corresponding author
Thompson, Leslie M
Venue
Nature Neuroscience
Published
2017-03-20
Volume
20
Issue
5
Pages
648-660
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2598373555
Cited by
221
References
92
Citations by year
2026: 13 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 22 · 2021: 44 · 2020: 27 · 2019: 43 · 2018: 26 · 2017: 4
FWCI
13.38
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Iris (University of Trento) (submittedVersion, other-oa)
  • PMC
Funders
  • American Heart Association
  • Hereditary Disease Foundation
  • CHDI Foundation
  • Cedars-Sinai Medical Center
  • Ionis Pharmaceuticals
  • Hellman Family Foundation
  • European Commission (2014‐2020)
  • Generalitat de Catalunya
  • National Institutes of Health (UL1TR001414, NS091046, CA-62203, NS078370)
  • University of California, Irvine (CA-62203)
  • Instituto de Salud Carlos III
  • European Regional Development Fund (2014-2020’, RD12/0019/0002)
  • National Cancer Institute (P30CA062203)
  • National Institute of General Medical Sciences (R01GM089903, T32GM087237, T32GM008334)
  • National Institute of Neurological Disorders and Stroke (RC2NS069422, R01NS084298, R01NS091161, U54NS091046, U24NS078370, R37NS101996, R01NS086452, R01NS089076, R21NS090395, P50NS016367)
  • National Institute of Environmental Health Sciences (P30ES002109)
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
Huntington's disease, induced pluripotent stem cells, brain development, neuronal differentiation, glutamate signaling, GABA signaling, axon guidance, calcium influx, histone modifications, epigenetics, polyglutamine expansion, mutant huntingtin, striatal development, synaptic pathology, cognitive impairment, R6/2 mice, small molecule rescue
MeSH terms
Huntingtin Protein, Animals, Cells, Cultured, Corpus Striatum, Histones, Humans, Huntington Disease, Isoxazoles, Mice, Transgenic, Nerve Tissue Proteins, Neurons, Peptides, Thiophenes, Signal Transduction, Gene Expression, Gene Expression Profiling, Mice, Basic Helix-Loop-Helix Proteins, Neurogenesis, Gene Knockdown Techniques, Induced Pluripotent Stem Cells, Epigenomics, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review